StockData
TuHURA Biosciences, Inc./NV logo

TuHURA Biosciences, Inc./NV (HURA) stock

HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$1.37−0.03 (-2.14%)

Close on Nov 18, 2026Market cap $87.31MP/E –Yield –

TuHURA Biosciences r&d expenses

Research and development expenses are spending on new products and technology.

TuHURA Biosciences's R&D Expenses for the twelve months ending Jun 30, 2026 was $22.88M. For fiscal 2025 it was $20.53M, up 120.5% from the year before. Over ten years it grew 29.5% a year on average. The highest annual figure on record is $20.53M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$20.53M+120.5%
FY2023Jun 30, 2023$9.31M-38.6%
FY2022Jun 30, 2022$15.17M+28.4%
FY2021Jun 30, 2021$11.82M+225.5%
FY2020Jun 30, 2020$3.63M-0.9%
FY2019Jun 30, 2019$3.66M–
FY2018Jun 30, 2018-$7.13M–
FY2017Jun 30, 2017-$5.00M-248.9%
FY2016Jun 30, 2016$3.36M+43.5%
FY2013Dec 31, 2013$2.34M+51.1%
FY2012Dec 31, 2012$1.55M+47.5%
FY2011Dec 31, 2011$1.05M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$6.62M+34.4%
Q1 FY2026CQ1 2026Mar 31, 2026$5.23M+14.2%
Q4 FY2025CQ4 2025Dec 31, 2025$6.06M+191.7%
Q3 FY2025CQ3 2025Sep 30, 2025$4.97M+147.8%
Q2 FY2025CQ2 2025Jun 30, 2025$4.93M+139.3%
Q1 FY2025CQ1 2025Mar 31, 2025$4.58M+44.5%
Q4 FY2023CQ2 2023Jun 30, 2023$2.08M-48.2%
Q3 FY2023CQ1 2023Mar 31, 2023$2.01M-42.3%
Q2 FY2023CQ4 2022Dec 31, 2022$2.06M-47.2%
Q1 FY2023CQ3 2022Sep 30, 2022$3.17M-16.4%
Q4 FY2022CQ2 2022Jun 30, 2022$4.00M-0.7%
Q3 FY2022CQ1 2022Mar 31, 2022$3.47M-9.6%
Q2 FY2022CQ4 2021Dec 31, 2021$3.90M+51.0%
Q1 FY2022CQ3 2021Sep 30, 2021$3.79M+179.5%
Q4 FY2021CQ2 2021Jun 30, 2021$4.03M+210.6%
Q3 FY2021CQ1 2021Mar 31, 2021$3.84M+327.5%
Q2 FY2021CQ4 2020Dec 31, 2020$2.58M+262.9%
Q1 FY2021CQ3 2020Sep 30, 2020$1.36M+88.2%
Q4 FY2020CQ2 2020Jun 30, 2020$1.30M+35.2%
Q3 FY2020CQ1 2020Mar 31, 2020$899.00K+22.2%
Q2 FY2020CQ4 2019Dec 31, 2019$712.00K-24.8%
Q1 FY2020CQ3 2019Sep 30, 2019$721.00K-29.3%
Q4 FY2019CQ2 2019Jun 30, 2019$959.84K-46.1%
Q3 FY2019CQ1 2019Mar 31, 2019$735.84K-65.6%
Q2 FY2019CQ4 2018Dec 31, 2018$947.25K-51.0%
Q1 FY2019CQ3 2018Sep 30, 2018$1.02M-50.6%
Q3 FY2018CQ1 2018Mar 31, 2018$1.78M+63.9%
Q2 FY2018CQ4 2017Dec 31, 2017$2.14M+91.1%
Q1 FY2018CQ3 2017Sep 30, 2017$1.93M+164.0%
Q4 FY2017CQ2 2017Jun 30, 2017$2.06M-62.8%
Q3 FY2017CQ1 2017Mar 31, 2017$1.09M–
Q2 FY2017CQ4 2016Dec 31, 2016$1.12M+42.0%
Q1 FY2017CQ3 2016Sep 30, 2016$732.73K+21.3%
Q4 FY2016CQ2 2016Jun 30, 2016$5.54M–
Q3 FY2016CQ1 2016Mar 31, 2016-$790.32K–
Q2 FY2016CQ4 2015Dec 31, 2015$789.19K–
Q1 FY2016CQ3 2015Sep 30, 2015$603.85K–
Q4 FY2013CQ4 2013Dec 31, 2013-$566.06K–
Q3 FY2013CQ3 2013Sep 30, 2013-$560.24K–

More TuHURA Biosciences figures

See a number that looks wrong?